Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Consolidated Net Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,885 Cr₹1,388 Cr₹715 Cr₹170 Cr₹441 Cr

What is the latest Consolidated Net Profit of NATCO PHARMA ?

The latest Consolidated Net Profit ratio of NATCO PHARMA is ₹1,885 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,885 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹441 Cr

How is Consolidated Net Profit of NATCO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,885 Cr
35.81
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.44
Mar2021 ₹441 Cr -

Compare Consolidated Net Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,973.9 Cr -2% -1.5% -29.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,019.0 Cr -3.5% -5.4% -3.2% Stock Analytics
DIVIS LABORATORIES ₹168,752.0 Cr -3.6% 0.2% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,542.0 Cr -0.5% 5.9% 20.3% Stock Analytics
CIPLA ₹115,883.0 Cr -1.8% -4.8% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,024.7 Cr -1.7% -7.3% -12.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2%

-1.5%

-29.6%

SENSEX

-1.9%

-2.2%

7.4%


You may also like the below Video Courses